These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 22203471

  • 1. Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.
    Li X, Xin S, Yang D, Li X, He Z, Che X, Wang J, Chen F, Wang X, Song X.
    J Cancer Res Clin Oncol; 2012 Mar; 138(3):529-35. PubMed ID: 22203471
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.
    Cell Physiol Biochem; 2014 Mar; 33(6):1631-42. PubMed ID: 24902663
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of PDCD4 expression in human salivary adenoid cystic carcinoma.
    Qi C, Shao Y, Li N, Zhang C, Zhao M, Gao F.
    Med Oncol; 2013 Mar; 30(1):491. PubMed ID: 23389919
    [Abstract] [Full Text] [Related]

  • 4. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.
    Li W, Liu M, Feng Y, Xu YF, Che JP, Wang GC, Zheng JH, Gao HJ.
    Int J Clin Exp Pathol; 2013 Jan; 6(6):1086-94. PubMed ID: 23696926
    [Abstract] [Full Text] [Related]

  • 6. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
    Deng Q, Wang Z, Wang L, Zhang L, Xiang X, Wang Z, Chong T.
    Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA‑21 contributes to renal cell carcinoma cell invasiveness and angiogenesis via the PDCD4/c‑Jun (AP‑1) signalling pathway.
    Fan B, Jin Y, Zhang H, Zhao R, Sun M, Sun M, Yuan X, Wang W, Wang X, Chen Z, Liu W, Yu N, Wang Q, Liu T, Li X.
    Int J Oncol; 2020 Jan; 56(1):178-192. PubMed ID: 31789394
    [Abstract] [Full Text] [Related]

  • 8. HuR expression is a marker of poor prognosis in renal cell carcinoma.
    Ronkainen H, Vaarala MH, Hirvikoski P, Ristimäki A.
    Tumour Biol; 2011 Jun; 32(3):481-7. PubMed ID: 21161467
    [Abstract] [Full Text] [Related]

  • 9. The role of c-Met in prognosis and clinicopathology of renal cell carcinoma: Results from a single-centre study and systematic review.
    Chen S, Zhu Y, Cui J, Wang Y, Xia Y, Song J, Cheng S, Zhou C, Zhang D, Zhang B, Shi B.
    Urol Oncol; 2017 Aug; 35(8):532.e15-532.e23. PubMed ID: 28427859
    [Abstract] [Full Text] [Related]

  • 10. Glucose-regulated protein 78 positivity as a predictor of poor survival in patients with renal cell carcinoma.
    Kuroda K, Horiguchi A, Asano T, Ito K, Asakuma J, Sato A, Yoshii H, Hayakawa M, Sumitomo M, Asano T.
    Urol Int; 2011 Aug; 87(4):450-6. PubMed ID: 22076227
    [Abstract] [Full Text] [Related]

  • 11. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y, Sun B, Zhao X, Liu Z, Wang X, Yao X, Dong X, Chi J.
    J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
    [Abstract] [Full Text] [Related]

  • 12. Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.
    Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.
    Mod Pathol; 2012 Jan; 25(1):112-21. PubMed ID: 21983937
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J.
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [Abstract] [Full Text] [Related]

  • 14. Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.
    Miyata Y, Kanda S, Sakai H, Greer PA.
    Cancer Sci; 2013 Jun; 104(6):681-6. PubMed ID: 23445469
    [Abstract] [Full Text] [Related]

  • 15. Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.
    Ronkainen H, Vaarala MH, Kauppila S, Soini Y, Paavonen TK, Rask J, Hirvikoski P.
    Oncol Rep; 2009 Jun; 21(6):1519-23. PubMed ID: 19424632
    [Abstract] [Full Text] [Related]

  • 16. Up-regulation of flotillin-2 is associated with renal cell carcinoma progression.
    Yan Y, Yang FQ, Zhang HM, Che J, Zheng JH.
    Tumour Biol; 2014 Oct; 35(10):10479-86. PubMed ID: 25053596
    [Abstract] [Full Text] [Related]

  • 17. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
    Xu Z, Liu Y, Yang Y, Wang J, Zhang G, Liu Z, Fu H, Wang Z, Liu H, Xu J.
    Oncotarget; 2017 Jan 31; 8(5):7548-7558. PubMed ID: 27911274
    [Abstract] [Full Text] [Related]

  • 18. Expression of CD105 cancer stem cell marker in three subtypes of renal cell carcinoma.
    Saeednejad Zanjani L, Madjd Z, Abolhasani M, Shariftabrizi A, Rasti A, Asgari M.
    Cancer Biomark; 2018 Jan 31; 21(4):821-837. PubMed ID: 29286924
    [Abstract] [Full Text] [Related]

  • 19. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
    Ljungberg B, Bozoky B, Kovacs G, Stattin P, Farrelly E, Nylander K, Landberg G.
    Scand J Urol Nephrol; 2001 Feb 31; 35(1):15-20. PubMed ID: 11291681
    [Abstract] [Full Text] [Related]

  • 20. The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.
    Sun D, Lu J, Ding K, Bi D, Niu Z, Cao Q, Zhang J, Ding S.
    Med Oncol; 2013 Mar 31; 30(1):476. PubMed ID: 23371254
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.